An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant

Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic against the ongoing COVID-19 pandemic. However, the continuous emergence of neutralizing antibody escape variants makes it challenging for antibody therapeutics based on monospecific nAbs. Here, we generated an IgG-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Mengqi, Zhu, Yanzhi, Liu, Guanlan, Wang, Yujie, Wang, Guanxi, Zhang, Guozhong, Ye, Lilin, Qian, Zhaohui, Liu, Pinghuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173222/
https://www.ncbi.nlm.nih.gov/pubmed/37521533
http://dx.doi.org/10.1186/s44280-023-00012-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173222/
https://www.ncbi.nlm.nih.gov/pubmed/37521533
http://dx.doi.org/10.1186/s44280-023-00012-0

Ejemplares similares